China steers clear of deflation in 2025 as December CPI reaches its highest point in 34 months
China's Consumer Inflation Reaches Highest Point Since Early 2023
In December, China's annual consumer price inflation climbed to 0.8%, edging up from the previous month's 0.7% and marking the highest rate observed since February 2023. This outcome matched analysts' forecasts. Similar to November, the main factor behind the increase was higher food costs. Food prices accelerated to a year-on-year growth of 1.1%, the fastest pace in over a year. Notably, fresh vegetables and fruits experienced the most significant monthly gains, with prices rising by 18.2% and 4.4% year-on-year, respectively. Although pork prices continued their downward trend, the decline eased slightly, with the annual rate improving by 0.4 percentage points to -14.6%. This marks the third consecutive month of improvement in the year-on-year pork price figures.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Stan Druckenmiller backs trade.xyz, ICE partnership targets US perpetual futures
Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours
Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.
Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare
On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.
Crypto prices
More
